Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record and its study details, eligibility criteria, locations, outcomes, and results information are displayed instead of an error page.SummaryDifference53%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice about NIH’s terminology transition appears above the unchanged 403 error page.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record, replacing the previous study content with a generic error screen. This blocks access to the core information and navigation for the study, so users cannot view details, locations, or related materials.SummaryDifference19%

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.